{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T23:47:04Z","timestamp":1790466424815,"version":"4.1.0"},"reference-count":289,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejmech.2020.112955","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T19:51:28Z","timestamp":1603396288000},"page":"112955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["An insight into the recent development of the clinical candidates for the treatment of malaria and their target proteins"],"prefix":"10.1016","volume":"210","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4992-096X","authenticated-orcid":false,"given":"Hari","family":"Madhav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9779-2056","authenticated-orcid":false,"given":"Nasimul","family":"Hoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2020.112955_bib1","author":"WHO, Malaria"},{"key":"10.1016\/j.ejmech.2020.112955_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/17460441.2020.1691996","article-title":"New directions in antimalarial target validation","volume":"15","author":"Batista","year":"2020","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2020.112955_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007943","article-title":"Getting in: the structural biology of malaria invasion","volume":"15","author":"Kumar","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2020.112955_bib4","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2353\/ajpath.2010.091090","article-title":"Cerebral malaria","volume":"176","author":"Desruisseaux","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2020.112955_bib5","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1016\/j.bmcl.2013.03.067","article-title":"Recent advances in malaria drug discovery","volume":"23","author":"Biamonte","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112955_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.chom.2018.02.008","article-title":"A\u00a0sleeping area of malaria research awakes","volume":"23","author":"Winzeler","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2020.112955_bib7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.pt.2011.09.004","article-title":"A\u00a0toolbox to study liver stage malaria","volume":"27","author":"Prud\u00eancio","year":"2011","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2020.112955_bib8","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1038\/s41598-018-21630-4","article-title":"Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP","volume":"8","author":"Bliss","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2020.112955_bib9","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.cell.2019.10.030","article-title":"Genome-scale identification of essential metabolic processes for targeting the plasmodium liver stage","volume":"179","author":"Stanway","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2020.112955_bib10","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41598-018-19149-9","article-title":"Malaria infected red blood cells release small regulatory RNAs through extracellular vesicles","volume":"8","author":"Babatunde","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2020.112955_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s42003-018-0046-2","article-title":"Erythrocytes lacking the Langereis blood group protein ABCB6 are resistant to the malaria parasite Plasmodium falciparum","volume":"1","author":"Egan","year":"2018","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ejmech.2020.112955_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/femsre\/fuz005","article-title":"Targeting malaria parasite invasion of red blood cells as an antimalarial strategy","volume":"43","author":"Burns","year":"2019","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2020.112955_bib13","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nature01107","article-title":"A\u00a0proteomic view of the Plasmodium falciparum life cycle","volume":"419","author":"Florens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112955_bib14","doi-asserted-by":"crossref","DOI":"10.4269\/ajtmh.18-0077","article-title":"Gametocyte development and carriage in Ghanaian individuals with uncomplicated plasmodium falciparum malaria","author":"Dinko","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2020.112955_bib15","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1016\/j.celrep.2019.11.073","article-title":"Inhibition of plasmepsin V activity blocks plasmodium falciparum gametocytogenesis and transmission to mosquitoes","volume":"29","author":"Jennison","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2020.112955_bib16","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1038\/s41598-018-24296-0","article-title":"Chromobacterium spp. mediate their anti-Plasmodium activity through secretion of the histone deacetylase inhibitor romidepsin","volume":"8","author":"Saraiva","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2020.112955_bib17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.ento.43.1.519","article-title":"Malaria parasite development in mosquitoes","volume":"43","author":"Beier","year":"1998","journal-title":"Annu. Rev. Entomol."},{"key":"10.1016\/j.ejmech.2020.112955_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev.micro.091208.073403","article-title":"Malaria parasite development in the mosquito and infection of the mammalian host","volume":"63","author":"Aly","year":"2009","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112955_bib19","first-page":"144","article-title":"Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria, Malar","volume":"10","author":"Achan","year":"2011","journal-title":"J"},{"key":"10.1016\/j.ejmech.2020.112955_bib20","doi-asserted-by":"crossref","DOI":"10.1021\/ja01233a516","article-title":"The total synthesis OF quinine 1","volume":"66","author":"Woodward","year":"1944","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.112955_bib21","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1021\/ja004325r","article-title":"The first stereoselective total synthesis of quinine","volume":"123","author":"Stork","year":"2001","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.112955_bib22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/35078178","article-title":"Synthetic lessons from quinine","volume":"411","author":"Weinreb","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112955_bib23","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1590\/0001-3765201820170830","article-title":"Current antimalarial therapies and advances in the development of semi-synthetic artemisinin derivatives","volume":"90","author":"Pinheiro","year":"2018","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.ejmech.2020.112955_bib24","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1128\/AAC.00100-12","article-title":"Sontochin as a guide to the development of drugs against chloroquine-resistant malaria","volume":"56","author":"Pou","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib25","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1128\/AAC.42.11.2973","article-title":"Central role of hemoglobin degradation in mechanisms of action of 4-aminoquinolines, quinoline methanols, and phenanthrene methanols","volume":"42","author":"Mungthin","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib26","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejmech.2013.05.046","article-title":"Synthesis of 4-aminoquinoline\u2013pyrimidine hybrids as potent antimalarials and their mode of action studies","volume":"66","author":"Singh","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib27","series-title":"Encycl. Toxicol","first-page":"913","article-title":"Chloroquine\/hydroxychloroquine","author":"Qozi","year":"2014"},{"key":"10.1016\/j.ejmech.2020.112955_bib28","series-title":"Meyler\u2019s Side Eff. Drugs","first-page":"781","author":"Piperaquine","year":"2016"},{"key":"10.1016\/j.ejmech.2020.112955_bib29","series-title":"SAFETY OF 8-AMINOQUINOLINE ANTIMALARIAL MEDICINES","author":"Recht","year":"2014"},{"key":"10.1016\/j.ejmech.2020.112955_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJMe1816383","article-title":"Tafenoquine \u2014 a radical improvement?","volume":"380","author":"White","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2020.112955_bib31","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/1475-2875-13-418","article-title":"Primaquine: the risks and the benefits","volume":"13","author":"Ashley","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2020.112955_bib32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijpddr.2016.09.004","article-title":"Exploring the scope of new arylamino alcohol derivatives: synthesis, antimalarial evaluation, toxicological studies, and target exploration","volume":"6","author":"Quiliano","year":"2016","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2020.112955_bib33","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/415686a","article-title":"Medical need, scientific opportunity and the drive for antimalarial drugs","volume":"415","author":"Ridley","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112955_bib34","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/jac\/dkl104","article-title":"The past, present and future of antifolates in the treatment of Plasmodium falciparum infection","volume":"57","author":"Nzila","year":"2006","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/pr.57.1.4","article-title":"Mechanisms of resistance of malaria parasites to antifolates","volume":"57","author":"Gregson","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2020.112955_bib36","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/AAC.41.6.1369","article-title":"New quinoline di-Mannich base compounds with greater antimalarial activity than chloroquine, amodiaquine, or pyronaridine","volume":"41","author":"Kotecka","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib37","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1128\/AAC.43.6.1525","article-title":"In\u00a0vitro activities of pyronaridine, alone and in combination with other antimalarial drugs, against Plasmodium falciparum","volume":"43","author":"Ringwald","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib38","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1128\/AAC.00451-13","article-title":"In\u00a0vitro and in\u00a0vivo antimalarial efficacies of optimized tetracyclines, antimicrob","volume":"57","author":"Draper","year":"2013","journal-title":"Agents Chemother"},{"key":"10.1016\/j.ejmech.2020.112955_bib39","author":"Biswas"},{"key":"10.1016\/j.ejmech.2020.112955_bib40","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1749-6632.1952.tb22668.x","article-title":"The use OF antibiotics IN the treatment OF malaria","volume":"55","author":"Coatney","year":"1952","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2020.112955_bib41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4269\/ajtmh.2011.10-0285","article-title":"Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis","volume":"84","author":"Magill","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2020.112955_bib42","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s12936-015-0980-0","article-title":"Tetracyclines in malaria","volume":"14","author":"Gaillard","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2020.112955_bib43","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1128\/AAC.38.3.511","article-title":"Antimalarial effects of rifampin in Plasmodium vivax malaria","volume":"38","author":"Pukrittayakamee","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib44","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/1475-2875-13-299","article-title":"Interaction between rifampicin, amodiaquine and artemether in mice infected with chloroquine resistant Plasmodium berghei","volume":"13","author":"Badejo","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2020.112955_bib45","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1128\/AAC.46.8.2315-2320.2002","article-title":"Clindamycin as an antimalarial drug: review of clinical trials","volume":"46","author":"Lell","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1475-2875-11-2","article-title":"Clindamycin plus quinine for treating uncomplicated falciparum malaria: a systematic review and meta-analysis","volume":"11","author":"Obonyo","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2020.112955_bib47","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/424603","article-title":"Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria","volume":"190","author":"Borrmann","year":"2004","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112955_bib48","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1086\/430309","article-title":"Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial","volume":"40","author":"Ramharter","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112955_bib49","doi-asserted-by":"crossref","DOI":"10.4269\/ajtmh.1983.32.221","article-title":"Effects of antibiotics on Plasmodium falciparum in\u00a0vitro","volume":"32","author":"Geary","year":"1983","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2020.112955_bib50","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2174\/156652410791065273","article-title":"Antibiotics in malaria therapy and their effect on the parasite apicoplast","volume":"10","author":"Pradel","year":"2010","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ejmech.2020.112955_bib51","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12936-016-1613-y","article-title":"Antibiotics in malaria therapy: which antibiotics except tetracyclines and macrolides may be used against malaria?","volume":"15","author":"Gaillard","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2020.112955_bib52","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.2147\/DDDT.S118116","article-title":"Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold","volume":"10","author":"Rudrapal","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2020.112955_bib53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1128\/mr.60.2.301-315.1996","article-title":"Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy","volume":"60","author":"Meshnick","year":"1996","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2020.112955_bib54","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0163-7258(90)90053-5","article-title":"Metabolism of antimalarial sesquiterpene lactones","volume":"48","author":"Lee","year":"1990","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2020.112955_bib55","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.3887571","article-title":"Qinghaosu (artemisinin): an antimalarial drug from China","volume":"228","author":"Klayman","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2020.112955_bib56","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2471","article-title":"The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine","volume":"17","author":"Tu","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2020.112955_bib57","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1128\/AAC.00183-15","article-title":"Stability of the antimalarial drug dihydroartemisinin under physiologically relevant conditions: implications for clinical treatment and pharmacokinetic and in\u00a0vitro assays","volume":"59","author":"Parapini","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib58","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1021\/jo102392p","article-title":"Stereolability of dihydroartemisinin, an antimalarial drug: a comprehensive kinetic investigation. Part 2","volume":"76","author":"Cabri","year":"2011","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib59","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1586\/eri.09.53","article-title":"Artemether-lumefantrine: an oral antimalarial for uncomplicated malaria in children","volume":"7","author":"Adjei","year":"2009","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ejmech.2020.112955_bib60","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1586\/14787210.2.2.181","article-title":"Coartemether (artemether and lumefantrine): an oral antimalarial drug","volume":"2","author":"Wernsdorfer","year":"2004","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ejmech.2020.112955_bib61","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1021\/jm00398a026","article-title":"Arteether, a new antimalarial drug: synthesis and antimalarial properties","volume":"31","author":"Brossi","year":"1988","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib62","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0014-4894(90)90092-Q","article-title":"Plasmodium berghei: the antimalarial action of artemisinin and sodium artelinate in\u00a0vivo and in\u00a0vitro, studied by flow cytometry","volume":"70","author":"van Vianen","year":"1990","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2020.112955_bib63","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.biomaterials.2018.02.026","article-title":"Liposomes of dimeric artesunate phospholipid: a combination of dimerization and self-assembly to combat malaria","volume":"163","author":"Ismail","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejmech.2020.112955_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02476-17","article-title":"Characterising blood stage antimalarial drug minimum inhibitory concentrations in\u00a0vivo using reinfection patterns","author":"Watson","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2018.03.045","article-title":"Synthesis and study of the antimalarial cardamom peroxide","author":"Hu","year":"2018","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2020.112955_bib66","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/00034983.1993.11812745","article-title":"The chemotherapy of rodent malaria. L. The activities of some synthetic 1,2,4-trioxanes against chloroquine-sensitive and chloroquine-resistant parasites. Part 3: observations on \u2018Fenozan-50F\u2019, a difluorinated 3,3\u2032-spirocyclopentane 1,2,4-trioxane","volume":"87","author":"Peters","year":"1993","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.ejmech.2020.112955_bib67","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1086\/655831","article-title":"Arterolane, a new synthetic trioxolane for treatment of uncomplicated plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial","volume":"51","author":"Valecha","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112955_bib68","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1128\/AAC.01305-09","article-title":"Probing the antimalarial mechanism of artemisinin and OZ277 (Arterolane) with nonperoxidic isosteres and nitroxyl radicals","volume":"54","author":"Fugi","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib69","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/2229-5070.175081","article-title":"Antimalarial drug resistance: an overview","volume":"6","author":"Antony","year":"2016","journal-title":"Tropenmed. Parasitol."},{"key":"10.1016\/j.ejmech.2020.112955_bib70","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jmgm.2016.10.022","article-title":"De novo lead optimization of triazine derivatives identifies potent antimalarials","volume":"71","author":"Shandilya","year":"2017","journal-title":"J.\u00a0Mol. Graph. Model."},{"issue":"80","key":"10.1016\/j.ejmech.2020.112955_bib71","first-page":"351","article-title":"Multidrug evolutionary strategies to reverse antibiotic resistance","author":"Baym","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2020.112955_bib72","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4269\/ajtmh.1961.10.5","article-title":"Observations on two plasmodium falciparum infections with an abnormal response to chloroquine","volume":"10","author":"Moore","year":"1961","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2020.112955_bib73","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/322858","article-title":"Chloroquine-resistant malaria","volume":"184","author":"Wellems","year":"2001","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112955_bib74","doi-asserted-by":"crossref","first-page":"14552","DOI":"10.1038\/srep14552","article-title":"Mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, enlarge the parasite\u2019s food vacuole and alter drug sensitivities","volume":"5","author":"Pulcini","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2020.112955_bib75","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35005132","article-title":"The structure of malaria pigment \u03b2-haematin","volume":"404","author":"Pagola","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112955_bib76","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1128\/AAC.00666-08","article-title":"Chloroquine resistance-conferring mutations in pfcrt give rise to a chloroquine-associated H+ leak from the malaria parasite\u2019s digestive vacuole","volume":"52","author":"Lehane","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib77","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.pt.2012.08.002","article-title":"PfCRT and its role in antimalarial drug resistance","volume":"28","author":"Ecker","year":"2012","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2020.112955_bib78","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1073\/pnas.1417102112","article-title":"Plasmodium falciparum chloroquine resistance transporter is a H\u00a0+ -coupled polyspecific nutrient and drug exporter","volume":"112","author":"Juge","year":"2015","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2020.112955_bib79","first-page":"1","article-title":"Role of different Pf crt and Pf mdr-1 mutations in conferring resistance to antimalaria drugs in plasmodium falciparum","author":"Ibraheem","year":"2014","journal-title":"Malar. Res. Treat."},{"key":"10.1016\/j.ejmech.2020.112955_bib80","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0092-8674(00)81370-7","article-title":"MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine","volume":"87","author":"van Helvoort","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2020.112955_bib81","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/319865","article-title":"Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda","volume":"183","author":"Dorsey","year":"2001","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112955_bib82","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12936-015-0581-y","article-title":"PfMDR2 and PfMDR5 are dispensable for Plasmodium falciparum asexual parasite multiplication but change in\u00a0vitro susceptibility to anti-malarial drugs","volume":"14","author":"van der Velden","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2020.112955_bib83","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.actatropica.2011.08.013","article-title":"In\u00a0vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria","volume":"120","author":"Folarin","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejmech.2020.112955_bib84","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4269\/ajtmh.2006.75.155","article-title":"Association between mutations in plasmodium falciparum chloroquine resistance transporter and P. Falciparum multidrug resistance 1 genes and in\u00a0vivo amodiaquine resistance in P. Falciparum malaria\u2013infected children in Nigeria","volume":"75","author":"Kyle","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2020.112955_bib85","article-title":"Short report: association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the upper Nile in southern Sudan","volume":"69","author":"Ochong","year":"2003","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2020.112955_bib86","series-title":"Curr. Top. Malar","article-title":"Structure and functional differentiation of PfCRT mutation in chloroquine resistance (CQR) in plasmodium falciparum malaria","author":"Parida","year":"2016"},{"key":"10.1016\/j.ejmech.2020.112955_bib87","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/srep01734","article-title":"A\u00a0whole cell pathway screen reveals seven novel chemosensitizers to combat chloroquine resistant malaria","volume":"3","author":"Ch\u2019ng","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2020.112955_bib88","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1590\/0074-0276130274","article-title":"Genetics of chloroquine-resistant malaria: a haplotypic view","volume":"108","author":"Awasthi","year":"2013","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ejmech.2020.112955_bib89","author":"Farooq"},{"key":"10.1016\/j.ejmech.2020.112955_bib90","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1473-3099(02)00239-6","article-title":"Epidemiology of drug-resistant malaria","volume":"2","author":"Wongsrichanalai","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112955_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/363417","article-title":"Border malaria associated with multidrug resistance on Thailand-Myanmar and Thailand-Cambodia borders: transmission dynamic, vulnerability, and surveillance","volume":"2013","author":"Bhumiratana","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2020.112955_bib92","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/35002615","article-title":"Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum","volume":"403","author":"Reed","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112955_bib93","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1365-2958.2005.04729.x","article-title":"pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum","volume":"57","author":"Sidhu","year":"2005","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112955_bib94","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/nyas.12662","article-title":"The molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations","volume":"1342","author":"Heinberg","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejmech.2020.112955_bib95","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4269\/ajtmh.15-0007","article-title":"Antimalarial drug resistance: literature review and activities and findings of the ICEMR network","volume":"93","author":"Cui","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2020.112955_bib96","first-page":"267","article-title":"Deployment and utilization of next-generation sequencing of Plasmodium falciparum to guide anti-malarial drug policy decisions in sub-Saharan Africa: opportunities and challenges, Malar","volume":"18","author":"Ishengoma","year":"2019","journal-title":"J"},{"key":"10.1016\/j.ejmech.2020.112955_bib97","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1472-8206.2003.00164.x","article-title":"The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum","volume":"17","author":"Le Bras","year":"2003","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112955_bib98","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760180425","article-title":"Lack of quadruple and quintuple mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax isolates from Brazilian endemic areas","volume":"114","author":"Gomes","year":"2019","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ejmech.2020.112955_bib99","doi-asserted-by":"crossref","unstructured":"H.A. Antony, S.C. Parija, Antimalarial drug resistance: An overview., Tropenmed. Parasitol. 6 (n.d.) 30\u201341. https:\/\/doi.org\/10.4103\/2229-5070.175081.","DOI":"10.4103\/2229-5070.175081"},{"key":"10.1016\/j.ejmech.2020.112955_bib100","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1073\/pnas.94.4.1124","article-title":"Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase","volume":"94","author":"Sirawaraporn","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2020.112955_bib101","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpddr.2013.07.001","article-title":"Polymorphism in dhfr\/dhps genes, parasite density and ex\u00a0vivo response to pyrimethamine in Plasmodium falciparum malaria parasites in Thies, Senegal","volume":"3","author":"Ndiaye","year":"2013","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2020.112955_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007223","article-title":"The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis","volume":"13","author":"Juma","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2020.112955_bib103","doi-asserted-by":"crossref","first-page":"18796","DOI":"10.1073\/pnas.1116162108","article-title":"Malaria antifolate resistance with contrasting Plasmodium falciparum dihydrofolate reductase (DHFR) polymorphisms in humans and Anopheles mosquitoes","volume":"108","author":"Mharakurwa","year":"2011","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2020.112955_bib104","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/20477724.2019.1639018","article-title":"Molecular surveillance of putative drug resistance markers of antifolate and artemisinin among imported Plasmodium falciparum in Qatar","volume":"113","author":"Bansal","year":"2019","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.ejmech.2020.112955_bib105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12936-019-2903-y","article-title":"Molecular detection of drug resistant malaria in Southern Thailand","volume":"18","author":"Noisang","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2020.112955_bib106","series-title":"Are We Headed for a New Era of Malaria Drug Resistance?","author":"Slivinski","year":"2019"},{"key":"10.1016\/j.ejmech.2020.112955_bib107","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12936-018-2265-x","article-title":"Efficacy and safety of artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Sudan: a systematic review and meta-analysis","volume":"17","author":"Adam","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2020.112955_bib108","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4269\/ajtmh.16-0171","article-title":"Diagnosis and treatment of plasmodium vivax malaria","volume":"95","author":"Baird","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2020.112955_bib109","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12936-018-2524-x","article-title":"Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania","volume":"17","author":"Kakolwa","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2020.112955_bib110","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2020.112955_bib111","author":"WHO"},{"key":"10.1016\/j.ejmech.2020.112955_bib112","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1365-3156.2006.01690.x","article-title":"Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia","volume":"11","author":"Denis","year":"2006","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ejmech.2020.112955_bib113","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMc0805011","article-title":"Artemisinin resistance in Cambodia 1 (ARC1) study consortium, evidence of artemisinin-resistant malaria in western Cambodia","volume":"359","author":"Noedl","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2020.112955_bib114","doi-asserted-by":"crossref","first-page":"a025619","DOI":"10.1101\/cshperspect.a025619","article-title":"Antimalarial drug resistance: a threat to malaria elimination","volume":"7","author":"Menard","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ejmech.2020.112955_bib115","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.pt.2017.01.004","article-title":"How to contain artemisinin- and multidrug-resistant falciparum malaria","volume":"33","author":"Dondorp","year":"2017","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2020.112955_bib116","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","article-title":"Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study","volume":"16","author":"Amaratunga","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112955_bib117","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","article-title":"A\u00a0surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study","volume":"17","author":"Witkowski","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112955_bib118","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","article-title":"Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study","volume":"19","author":"van der Pluijm","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112955_bib119","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12916-015-0539-5","article-title":"Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in\u00a0vitro assays: retrospective and prospective investigations","volume":"13","author":"Duru","year":"2015","journal-title":"BMC Med."},{"key":"10.1016\/j.ejmech.2020.112955_bib120","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02445-18","article-title":"Baseline ex\u00a0vivo and molecular responses of plasmodium fa lciparum isolates to piperaquine before implementation of dihydroartemisinin-piperaquine in Senegal","volume":"63","author":"Robert","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib121","article-title":"Modeling prevention of malaria and selection of drug resistance with different dosing schedules of dihydroartemisinin-piperaquine preventive therapy during pregnancy in Uganda","volume":"63","author":"Wallender","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib122","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S1473-3099(19)30535-3","article-title":"Suboptimal dosing triggers artemisinin partner drug resistance","volume":"19","author":"Wang","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112955_bib123","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027738","article-title":"The effect of dose on the antimalarial efficacy of artesunate-mefloquine against Plasmodium falciparum malaria: a protocol for systematic review and individual patient data (IPD) meta-analysis","volume":"9","author":"Mansoor","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejmech.2020.112955_bib124","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/jmms.jmms_43_18","article-title":"Artemisinin resistance: cause for worry?","volume":"21","author":"Khera","year":"2019","journal-title":"J.\u00a0Mar. Med. Soc."},{"key":"10.1016\/j.ejmech.2020.112955_bib125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12936-019-2754-6","article-title":"Population pharmacokinetics and pharmacodynamics of the artesunate\u2013mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children","volume":"18","author":"Guidi","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2020.112955_bib126","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0140-6736(00)02505-8","article-title":"Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study","volume":"356","author":"Nosten","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2020.112955_bib127","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4269\/ajtmh.2007.76.641","article-title":"PfMDR1 and in\u00a0vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian\u2013Thai border","volume":"76","author":"Wongsrichanalai","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2020.112955_bib128","first-page":"10","article-title":"Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia, Malar","volume":"8","author":"Rogers","year":"2009","journal-title":"J"},{"key":"10.1016\/j.ejmech.2020.112955_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004551","article-title":"Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 Years of continuous deployment","volume":"4","author":"Carrara","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.ejmech.2020.112955_bib130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1475-2875-4-46","article-title":"A\u00a0randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand","volume":"4","author":"Hutagalung","year":"2005","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2020.112955_bib131","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-3156.2007.01843.x","article-title":"The role of pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa","volume":"12","author":"Sisowath","year":"2007","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ejmech.2020.112955_bib132","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/j.1365-3156.2006.01739.x","article-title":"Efficacy of artemether?lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia","volume":"11","author":"Denis","year":"2006","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.ejmech.2020.112955_bib133","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12936-019-2864-1","article-title":"High therapeutic efficacy of artemether\u2013lumefantrine and dihydroartemisinin\u2013piperaquine for the treatment of uncomplicated falciparum malaria in Somalia","volume":"18","author":"Warsame","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2020.112955_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2019.e00607","article-title":"False resistance after artemether\u2013lumefantrine treatment in a falciparum malaria patient in Turkey: a case report","volume":"18","author":"Koru","year":"2019","journal-title":"IDCases"},{"key":"10.1016\/j.ejmech.2020.112955_bib135","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0163-2019","article-title":"Therapeutic failure after regimen with artemether-lumefantrine combination therapy: a report of three cases in Benin City, Nigeria","volume":"52","author":"Ebohon","year":"2019","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.ejmech.2020.112955_bib136","article-title":"Efficacy and safety of pyronaridine-artesunate plus single-dose primaquine for the treatment of malaria in western Cambodia","volume":"63","author":"Leang","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib137","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1056\/NEJMc1713777","article-title":"Evidence of artemisinin-resistant plasmodium falciparum malaria in eastern India","volume":"379","author":"Das","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2020.112955_bib138","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1126\/science.1215966","article-title":"A\u00a0major genome region underlying artemisinin resistance in malaria","volume":"336","author":"Cheeseman","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2020.112955_bib139","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.1211205110","article-title":"Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia","volume":"110","author":"Takala-Harrison","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2020.112955_bib140","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/femsre\/fuw037","article-title":"The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread","volume":"41","author":"Woodrow","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2020.112955_bib141","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A\u00a0molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112955_bib142","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.pt.2016.05.010","article-title":"Artemisinin action and resistance in plasmodium falciparum","volume":"32","author":"Tilley","year":"2016","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2020.112955_bib143","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/infdis\/jiy673","article-title":"Artemisinin resistance and stage dependency of parasite clearance in falciparum malaria","volume":"219","author":"Intharabut","year":"2019","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112955_bib144","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","article-title":"Drug resistance in plasmodium","volume":"16","author":"Haldar","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112955_bib145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/2305062","article-title":"Status of artemisinin resistance in malaria parasite plasmodium falciparum from molecular analyses of the Kelch13 gene in southwestern Nigeria","author":"Oboh","year":"2018","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2020.112955_bib146","article-title":"Importance of kelch 13 C580Y mutation in the studies of artemisinin resistance in Plasmodium falciparum in Greater Mekong Subregion","author":"Zaw","year":"2019","journal-title":"J.\u00a0Microbiol. Immunol. Infect."},{"key":"10.1016\/j.ejmech.2020.112955_bib147","doi-asserted-by":"crossref","first-page":"12951","DOI":"10.1038\/s41598-018-31207-w","article-title":"Surveillance of antimalarial resistance pfcrt, Pfmdr1, and Pfkelch13 polymorphisms in african plasmodium falciparum imported to shandong Province, China","volume":"8","author":"Xu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2020.112955_bib148","author":"Dong"},{"key":"10.1016\/j.ejmech.2020.112955_bib149","doi-asserted-by":"crossref","first-page":"16690","DOI":"10.1038\/s41598-017-16866-5","article-title":"Prevalence of mutations linked to antimalarial resistance in Plasmodium falciparum from Chhattisgarh, Central India: a malaria elimination point of view","volume":"7","author":"Patel","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2020.112955_bib150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12936-019-2640-2","article-title":"Susceptibility of plasmodium falciparum to artemisinins and plasmodium vivax to chloroquine in Phuoc chien Commune, Ninh thuan Province, south-central Vietnam","volume":"18","author":"Phong","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2020.112955_bib151","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3347\/kjp.2019.57.4.369","article-title":"Molecular surveillance of Pfkelch13 and Pfmdr1 mutations in plasmodium falciparum isolates from southern Thailand","volume":"57","author":"Khammanee","year":"2019","journal-title":"Kor. J. Parasitol."},{"key":"10.1016\/j.ejmech.2020.112955_bib152","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nature14412","article-title":"A\u00a0molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria","volume":"520","author":"Mbengue","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112955_bib153","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12936-019-2916-6","article-title":"Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa?","volume":"18","author":"Foguim Tsombeng","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2020.112955_bib154","doi-asserted-by":"crossref","first-page":"12799","DOI":"10.1073\/pnas.1812317115","article-title":"Mutations in Plasmodium falciparum actin-binding protein coronin confer reduced artemisinin susceptibility","volume":"115","author":"Demas","year":"2018","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2020.112955_bib155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpddr.2019.10.001","article-title":"Profiles of Kelch mutations in Plasmodium falciparum across South Asia and their implications for tracking drug resistance","volume":"11","author":"Chhibber-Goel","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2020.112955_bib156","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpddr.2019.04.002","article-title":"In\u00a0vitro susceptibility of Plasmodium falciparum isolates from the China-Myanmar border area to artemisinins and correlation with K13 mutations","volume":"10","author":"Zhang","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug Resist"},{"key":"10.1016\/j.ejmech.2020.112955_bib157","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mib.2020.06.004","article-title":"The antimalarial resistome \u2013 finding new drug targets and their modes of action","volume":"57","author":"Carolino","year":"2020","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112955_bib158","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa6645","article-title":"A\u00a0long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria","volume":"7","author":"Phillips","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2020.112955_bib159","doi-asserted-by":"crossref","first-page":"16823","DOI":"10.1073\/pnas.1204556109","article-title":"Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target","volume":"109","author":"Yuthavong","year":"2012","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2020.112955_bib160","doi-asserted-by":"crossref","first-page":"9890","DOI":"10.1021\/acs.jmedchem.6b01265","article-title":"Identification of a potential antimalarial drug candidate from a series of 2-aminopyrazines by optimization of aqueous solubility and potency across the parasite life cycle","volume":"59","author":"Le Manach","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib161","article-title":"UCT943, a next-generation plasmodium falciparum PI4K inhibitor preclinical candidate for the treatment of malaria","volume":"62","author":"Brunschwig","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib162","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9735","article-title":"Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase","volume":"9","author":"Paquet","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2020.112955_bib163","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1021\/jm3001373","article-title":"3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential","volume":"55","author":"Younis","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib164","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpddr.2019.02.004","article-title":"Plasmodium knowlesi exhibits distinct in\u00a0vitro drug susceptibility profiles from those of Plasmodium falciparum","volume":"9","author":"van Schalkwyk","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug Resist"},{"key":"10.1016\/j.ejmech.2020.112955_bib165","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1038\/ncomms7715","article-title":"Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate","volume":"6","author":"Hameed P","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2020.112955_bib166","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00087-18","article-title":"Cell swelling induced by the antimalarial KAE609 (cipargamin) and other PfATP4-associated antimalarials","volume":"62","author":"Dennis","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib167","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1126\/science.1193225","article-title":"Spiroindolones, a potent compound class for the treatment of malaria","volume":"329","author":"Rottmann","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2020.112955_bib168","doi-asserted-by":"crossref","first-page":"E5455","DOI":"10.1073\/pnas.1414221111","article-title":"(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium","volume":"111","author":"Jim\u00e9nez-D\u00edaz","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2020.112955_bib169","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature19804","article-title":"Diversity-oriented synthesis yields novel multistage antimalarial inhibitors","volume":"538","author":"Kato","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112955_bib170","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/infdis\/jis418","article-title":"Identification of a new chemical class of antimalarials","volume":"206","author":"Brunner","year":"2012","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112955_bib171","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cmdc.201600298","article-title":"Discovery and characterization of ACT-451840: an antimalarial drug with a novel mechanism of action","volume":"11","author":"Boss","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2020.112955_bib172","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002138","article-title":"Characterization of novel antimalarial compound ACT-451840: preclinical assessment of activity and dose\u2013efficacy modeling","volume":"13","author":"Le Bihan","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejmech.2020.112955_bib173","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1128\/AAC.00791-16","article-title":"Atovaquone and ELQ-300 combination therapy as a novel dual-site cytochrome bc 1 inhibition strategy for malaria","volume":"60","author":"Stickles","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib174","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1021\/jm500147k","article-title":"Discovery, synthesis, and optimization of antimalarial 4(1 H )-Quinolone-3-Diarylethers","volume":"57","author":"Nilsen","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib175","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1080\/13543784.2018.1524871","article-title":"The early preclinical and clinical development of ganaplacide (KAF156), a novel antimalarial compound","volume":"27","author":"Koller","year":"2018","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejmech.2020.112955_bib176","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1021\/jm300041e","article-title":"Imidazolopiperazines: lead optimization of the second-generation antimalarial agents","volume":"55","author":"Nagle","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib177","first-page":"1","article-title":"Single ascending dose safety and pharmacokinetics of CDRI-97\/78: first-in-human study of a novel antimalarial drug","author":"Shafiq","year":"2014","journal-title":"Malar. Res. Treat."},{"key":"10.1016\/j.ejmech.2020.112955_bib178","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2018.00256","article-title":"Artemisinin derivatives and synthetic trioxane trigger apoptotic cell death in asexual stages of plasmodium","volume":"8","author":"Gunjan","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejmech.2020.112955_bib179","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrd.2018.156","article-title":"Malaria medicine box expands","volume":"17","author":"Mullard","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2020.112955_bib180","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14451","article-title":"A\u00a0novel multiple-stage antimalarial agent that inhibits protein synthesis","volume":"522","author":"Baraga\u00f1a","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112955_bib181","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/molecules23010100","article-title":"Increasing the strength and production of artemisinin and its derivatives","volume":"23","author":"Badshah","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112955_bib182","doi-asserted-by":"crossref","first-page":"15159","DOI":"10.1038\/ncomms15159","article-title":"A\u00a0tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance","volume":"8","author":"O\u2019Neill","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2020.112955_bib183","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1473-3099(15)00320-5","article-title":"Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial","volume":"16","author":"Phyo","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112955_bib184","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1073\/pnas.1015762108","article-title":"Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria","volume":"108","author":"Charman","year":"2011","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.ejmech.2020.112955_bib185","series-title":"Abstr. Pap. Am. Chem. Soc","article-title":"Discovery of pyrrolidinamides, a novel chemical class for malaria treatment: first time disclosure of the orally bioavailable clinical candidate GSK701","author":"Rami","year":"2018"},{"key":"10.1016\/j.ejmech.2020.112955_bib186","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12936-019-2724-z","article-title":"The past, present and future of anti-malarial medicines","volume":"18","author":"Tse","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2020.112955_bib187","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1128\/AAC.05326-11","article-title":"MK-4815, a potential new oral agent for treatment of malaria","volume":"56","author":"Powles","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib188","doi-asserted-by":"crossref","first-page":"14193","DOI":"10.1038\/ncomms14193","article-title":"SC83288 is a clinical development candidate for the treatment of severe malaria","volume":"8","author":"Pegoraro","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2020.112955_bib189","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12936-018-2279-4","article-title":"Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum","volume":"17","author":"Duffey","year":"2018","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2020.112955_bib190","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1093\/hmg\/ddv057","article-title":"Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors","volume":"24","author":"Ng","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmech.2020.112955_bib191","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature01097","article-title":"Genome sequence of the human malaria parasite Plasmodium falciparum","volume":"419","author":"Gardner","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112955_bib192","first-page":"79","article-title":"Metabolic enzymes as potential drug targets in Plasmodium falciparum","volume":"106","author":"Subbayya","year":"1997","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.ejmech.2020.112955_bib193","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","author":"Rts","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2020.112955_bib194","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1021\/jm015535x","article-title":"Specific inhibition of a family 1A dihydroorotate dehydrogenase by benzoate pyrimidine analogues","volume":"44","author":"Palfey","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib195","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1021\/bi702218c","article-title":"Analysis of flavin oxidation and electron-transfer inhibition in Plasmodium falciparum dihydroorotate dehydrogenase","volume":"47","author":"Malmquist","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2020.112955_bib196","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2174\/187152610791163336","article-title":"Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy","volume":"10","author":"Phillips","year":"2010","journal-title":"Infect. Disord. - Drug Targets"},{"key":"10.1016\/j.ejmech.2020.112955_bib197","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1021\/jm400938g","article-title":"Novel selective and potent inhibitors of malaria parasite dihydroorotate dehydrogenase: discovery and optimization of dihydrothiophenone derivatives","volume":"56","author":"Xu","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib198","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1021\/jm8001026","article-title":"Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite plasmodium falciparum","volume":"51","author":"Phillips","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib199","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1107\/S2053230X15000989","article-title":"The X-ray structure of Plasmodium falciparum dihydroorotate dehydrogenase bound to a potent and selective N-phenylbenzamide inhibitor reveals novel binding-site interactions","volume":"71","author":"Deng","year":"2015","journal-title":"Acta Crystallogr. Sect. F, Struct. Biol. Commun."},{"key":"10.1016\/j.ejmech.2020.112955_bib200","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1021\/acs.jcim.5b00680","article-title":"Identification of new human malaria parasite plasmodium falciparum dihydroorotate dehydrogenase inhibitors by pharmacophore and structure-based virtual screening","volume":"56","author":"Pavadai","year":"2016","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2020.112955_bib201","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/cbdd.13197","article-title":"Coptisine, a natural alkaloid from Coptidis Rhizoma , inhibits plasmodium falciparum dihydroorotate dehydrogenase","volume":"92","author":"Lang","year":"2018","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2020.112955_bib202","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3390\/molecules23061254","article-title":"Synthesis, design, and structure\u2013activity relationship of the Pyrimidone derivatives as novel selective inhibitors of plasmodium falciparum dihydroorotate dehydrogenase","volume":"23","author":"Xu","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112955_bib203","doi-asserted-by":"crossref","first-page":"102982","DOI":"10.1016\/j.bioorg.2019.102982","article-title":"Tetrahydro-1H,5H-pyrazolo[1,2-a]pyrazole-1-carboxylates as inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase","volume":"89","author":"Stra\u0161ek","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib204","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1021\/acsomega.8b01573","article-title":"Isoxazolopyrimidine-based inhibitors of plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity","volume":"3","author":"Kokkonda","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2020.112955_bib205","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejmech.2016.09.073","article-title":"Evaluation of 7-arylaminopyrazolo[1,5-a]pyrimidines as anti-Plasmodium falciparum, antimalarial, and Pf-dihydroorotate dehydrogenase inhibitors","volume":"126","author":"Azeredo","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib206","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1021\/acsmedchemlett.7b00030","article-title":"Discovery of antimalarial azetidine-2-carbonitriles that inhibit P. Falciparum dihydroorotate dehydrogenase","volume":"8","author":"Maetani","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112955_bib207","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1021\/acsinfecdis.6b00144","article-title":"A\u00a0triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with improved drug-like properties for treatment and prevention of malaria","volume":"2","author":"Phillips","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112955_bib208","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejmech.2018.11.044","article-title":"Hydroxyazole scaffold-based Plasmodium falciparum dihydroorotate dehydrogenase inhibitors: synthesis, biological evaluation and X-ray structural studies","volume":"163","author":"Pippione","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib209","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1021\/ml200143c","article-title":"Optimization of potent inhibitors of P. Falciparum dihydroorotate dehydrogenase for the treatment of malaria","volume":"2","author":"Skerlj","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112955_bib210","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejmech.2017.12.051","article-title":"Antimalarial naphthoquinones. Synthesis via click chemistry, in\u00a0vitro activity , docking to Pf DHODH and SAR of lapachol-based compounds","volume":"145","author":"Brand\u00e3o","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib211","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1128\/AAC.00301-12","article-title":"Combined spatial limitation around residues 16 and 108 of plasmodium falciparum dihydrofolate reductase explains resistance to cycloguanil","volume":"56","author":"Vanichtanankul","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib212","doi-asserted-by":"crossref","first-page":"1600156","DOI":"10.1002\/minf.201600156","article-title":"Pharmacoinformatic study on the selective inhibition of the Protozoan dihydrofolate reductase enzymes","volume":"36","author":"Sharma","year":"2017","journal-title":"Mol. Inform."},{"key":"10.1016\/j.ejmech.2020.112955_bib213","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.1021\/jm981130+","article-title":"Design, synthesis, and evaluation of inhibitors of trypanosomal and leishmanial dihydrofolate reductase","volume":"42","author":"Chowdhury","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib214","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1080\/07391102.2018.1540362","article-title":"Multicomplex-based pharmacophore modeling in conjunction with multi-target docking and molecular dynamics simulations for the identification of Pf DHFR inhibitors","volume":"37","author":"Manhas","year":"2019","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2020.112955_bib215","first-page":"14219","article-title":"First-in-human clinical trial to assess the safety, tolerability and pharmacokinetics of P218, a novel candidate for malaria chemoprotection","author":"Chughlay","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112955_bib216","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1016\/j.bmc.2017.10.017","article-title":"Discovery of new antimalarial agents: second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembly","volume":"25","author":"Chen","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib217","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.chembiol.2012.09.020","article-title":"The antimalarial natural product symplostatin 4 is a nanomolar inhibitor of the food vacuole falcipains","volume":"19","author":"Stolze","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2020.112955_bib218","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cclet.2017.11.041","article-title":"Novel dual inhibitors against FP-2 and PfDHFR as potential antimalarial agents: design, synthesis and biological evaluation","volume":"30","author":"Chen","year":"2019","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112955_bib219","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1021\/acsmedchemlett.8b00389","article-title":"Hybrid inhibitors of malarial dihydrofolate reductase with dual binding modes that can forestall resistance","volume":"9","author":"Tarnchompoo","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112955_bib220","doi-asserted-by":"crossref","first-page":"115158","DOI":"10.1016\/j.bmc.2019.115158","article-title":"6-Hydrophobic aromatic substituent pyrimethamine analogues as potential antimalarials for pyrimethamine-resistant Plasmodium falciparum","volume":"27","author":"Saepua","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib221","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.bmc.2017.05.054","article-title":"1,2,4-Triazole and 1,3,4-oxadiazole analogues: synthesis, MO studies, in silico molecular docking studies, antimalarial as DHFR inhibitor and antimicrobial activities","volume":"25","author":"Thakkar","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib222","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.pharep.2019.04.006","article-title":"In silico ADMET study, docking, synthesis and antimalarial evaluation of thiazole-1,3,5-triazine derivatives as Pf-DHFR inhibitor","volume":"71","author":"Sahu","year":"2019","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2020.112955_bib223","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ejmech.2013.01.032","article-title":"Azide-alkyne cycloaddition en route to 1 H -1,2,3-triazole-tethered 7-chloroquinoline-isatin chimeras: synthesis and antimalarial evaluation","volume":"62","author":"Raj","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib224","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bmc.2016.10.029","article-title":"Synthesis and evaluation of naphthyl bearing 1,2,3-triazole analogs as antiplasmodial agents, cytotoxicity and docking studies","volume":"25","author":"Balabadra","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib225","first-page":"12556","article-title":"Synthesis, in silico molecular docking, ADME evaluation and in\u00a0vitro antiplasmodial activity of pyrimidine-based hybrid molecules","volume":"4","author":"Chopra","year":"2019","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2020.112955_bib226","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1039\/C4NJ00978A","article-title":"Triazine\u2013pyrimidine based molecular hybrids: synthesis, docking studies and evaluation of antimalarial activity","volume":"38","author":"Kumar","year":"2014","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib227","doi-asserted-by":"crossref","first-page":"28171","DOI":"10.1039\/C4RA16032K","article-title":"Highly active 4-aminoquinoline\u2013pyrimidine based molecular hybrids as potential next generation antimalarial agents","volume":"5","author":"Manohar","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2020.112955_bib228","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bmcl.2013.12.009","article-title":"Design and synthesis of guanylthiourea derivatives as potential inhibitors of Plasmodium falciparum dihydrofolate reductase enzyme","volume":"24","author":"Adane","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112955_bib229","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejmech.2017.04.022","article-title":"Guanylthiourea derivatives as potential antimalarial agents: synthesis, in\u00a0vivo and molecular modelling studies","volume":"135","author":"Bhagat","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib230","doi-asserted-by":"crossref","first-page":"103094","DOI":"10.1016\/j.bioorg.2019.103094","article-title":"Design, synthesis and biological evaluation of 4-aminoquinoline-guanylthiourea derivatives as antimalarial agents","volume":"91","author":"Bhagat","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib231","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1006\/scel.1994.1047","article-title":"Protein kinases and cell cycle control","volume":"5","author":"Pines","year":"1994","journal-title":"Semin. Cell Biol."},{"key":"10.1016\/j.ejmech.2020.112955_bib232","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/s41416-018-0045-6","article-title":"New opportunities for kinase drug repurposing and target discovery","volume":"118","author":"Knapp","year":"2018","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2020.112955_bib233","doi-asserted-by":"crossref","first-page":"112025","DOI":"10.1016\/j.ejmech.2019.112025","article-title":"Dual-target kinase drug design: current strategies and future directions in cancer therapy","volume":"188","author":"Sun","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib234","doi-asserted-by":"crossref","first-page":"18045","DOI":"10.1038\/s41598-019-54557-5","article-title":"The selective GSK3 inhibitor, SAR502250, displays neuroprotective activity and attenuates behavioral impairments in models of neuropsychiatric symptoms of Alzheimer\u2019s disease in rodents","volume":"9","author":"Griebel","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2020.112955_bib235","doi-asserted-by":"crossref","DOI":"10.1038\/nrd.2017.267","article-title":"Erratum: JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"17","author":"Schwartz","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2020.112955_bib236","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cei.12248","article-title":"Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases","volume":"176","author":"Patterson","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejmech.2020.112955_bib237","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1093\/cvr\/cvy160","article-title":"Potential cardiovascular implications of Janus kinase inhibitors in immune mediated diseases","volume":"114","author":"Mehta","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejmech.2020.112955_bib238","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1136\/annrheumdis-2018-214846","article-title":"Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials","volume":"78","author":"Xie","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejmech.2020.112955_bib239","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.1021\/acs.jmedchem.8b00329","article-title":"Plasmodial kinase inhibitors: license to cure?","volume":"61","author":"Cabrera","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib240","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1152\/physrev.00028.2012","article-title":"Phosphoinositides: tiny lipids with giant impact on cell regulation","volume":"93","author":"Balla","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2020.112955_bib241","first-page":"1783","article-title":"Design of plasmodium falciparum PI(4)KIII\u03b2 inhibitor using molecular dynamics and molecular docking methods","volume":"2","author":"Rajkhowa","year":"2017","journal-title":"Chemistry"},{"key":"10.1016\/j.ejmech.2020.112955_bib242","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature12782","article-title":"Targeting Plasmodium PI(4)K to eliminate malaria","volume":"504","author":"McNamara","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2020.112955_bib243","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1021\/acsinfecdis.7b00276","article-title":"Using in\u00a0vitro evolution and whole genome analysis to discover next generation targets for antimalarial drug discovery","volume":"4","author":"Luth","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2020.112955_bib244","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1038\/s41598-017-02440-6","article-title":"The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites","volume":"7","author":"Dembele","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2020.112955_bib245","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1021\/acs.jmedchem.8b00648","article-title":"Identification, characterization, and optimization of 2,8-Disubstituted-1,5-naphthyridines as novel plasmodium falciparum phosphatidylinositol-4-kinase inhibitors with in\u00a0vivo efficacy in a humanized mouse model of malaria","volume":"61","author":"Kandepedu","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib246","doi-asserted-by":"crossref","first-page":"112012","DOI":"10.1016\/j.ejmech.2019.112012","article-title":"Discovery of 6\u2032-chloro-N-methyl-5\u2019-(phenylsulfonamido)-[3,3\u2032-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium","volume":"188","author":"Liang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib247","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/jac\/dky008","article-title":"Potent Plasmodium falciparum gametocytocidal compounds identified by exploring the kinase inhibitor chemical space for dual active antimalarials","volume":"73","author":"van der Watt","year":"2018","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib248","doi-asserted-by":"crossref","first-page":"29241","DOI":"10.1038\/srep29241","article-title":"A\u00a0high-sensitivity HPLC assay for measuring intracellular Na+ and K+ and its application to Plasmodium falciparum infected erythrocytes","volume":"6","author":"Winterberg","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2020.112955_bib249","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005647","article-title":"Na+ influx induced by new antimalarials causes rapid alterations in the cholesterol content and morphology of plasmodium falciparum","volume":"12","author":"Das","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ejmech.2020.112955_bib250","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.chom.2012.12.006","article-title":"Na+ regulation in the malaria parasite plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials","volume":"13","author":"Spillman","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2020.112955_bib251","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4269\/ajtmh.1988.39.157","article-title":"X-ray microanalysis of plasmodium falciparum and infected red blood cells: effects of qinghaosu and chloroquine on potassium, sodium, and phosphorus composition","volume":"39","author":"Kirk","year":"1988","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2020.112955_bib252","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1124\/mol.112.081224","article-title":"Solute restriction reveals an essential role for clag3 -associated channels in malaria parasite nutrient acquisition","volume":"82","author":"Pillai","year":"2012","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2020.112955_bib253","doi-asserted-by":"crossref","first-page":"C1576","DOI":"10.1152\/ajpcell.2001.280.6.C1576","article-title":"Perturbation of the pump-leak balance for Na\u00a0+ and K\u00a0+ in malaria-infected erythrocytes","volume":"280","author":"Staines","year":"2001","journal-title":"Am. J. Physiol. Physiol."},{"key":"10.1016\/j.ejmech.2020.112955_bib254","doi-asserted-by":"crossref","first-page":"13327","DOI":"10.1074\/jbc.RA118.003640","article-title":"Biochemical characterization and chemical inhibition of PfATP4-associated Na\u00a0+ -ATPase activity in Plasmodium falciparum membranes","volume":"293","author":"Rosling","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib255","doi-asserted-by":"crossref","first-page":"36841","DOI":"10.1074\/jbc.M507727200","article-title":"A\u00a0malaria parasite-encoded vacuolar H\u00a0+ -ATPase is targeted to the host erythrocyte","volume":"280","author":"Marchesini","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib256","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1242\/jeb.02014","article-title":"The V-type H+ ATPase: molecular structure and function, physiological roles and regulation","volume":"209","author":"Beyenbach","year":"2006","journal-title":"J.\u00a0Exp. Biol."},{"key":"10.1016\/j.ejmech.2020.112955_bib257","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijpddr.2015.07.001","article-title":"The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs","volume":"5","author":"Spillman","year":"2015","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ejmech.2020.112955_bib258","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4155\/fmc.15.177","article-title":"Spiroindolone NITD609 is a novel antimalarial drug that targets the P-type ATPase PfATP4","volume":"8","author":"Turner","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib259","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s40265-018-0911-9","article-title":"Drugs in development for malaria","volume":"78","author":"Ashley","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2020.112955_bib260","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1021\/cb500616x","article-title":"Mutations in the P-type cation-transporter ATPase 4, PfATP4, mediate resistance to both aminopyrazole and spiroindolone antimalarials","volume":"10","author":"Flannery","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2020.112955_bib261","doi-asserted-by":"crossref","first-page":"10292","DOI":"10.1038\/s41598-019-46500-5","article-title":"A\u00a04-cyano-3-methylisoquinoline inhibitor of Plasmodium falciparum growth targets the sodium efflux pump PfATP4","volume":"9","author":"Gilson","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2020.112955_bib262","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1039\/C5OB02517F","article-title":"Antimalarial activity of novel 4-cyano-3-methylisoquinoline inhibitors against Plasmodium falciparum: design, synthesis and biological evaluation","volume":"14","author":"Buskes","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib263","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1038\/ncomms6521","article-title":"Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum","volume":"5","author":"Vaidya","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2020.112955_bib264","doi-asserted-by":"crossref","first-page":"105676","DOI":"10.1039\/C6RA14016E","article-title":"Synthesis and antimalarial activity of new 4-aminoquinolines active against drug resistant strains","volume":"6","author":"Kondaparla","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2020.112955_bib265","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02347-17","article-title":"Synthesis, biological evaluation, and molecular modeling studies of chiral chloroquine analogues as antimalarial agents","volume":"62","author":"Kondaparla","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib266","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/acsmedchemlett.8b00496","article-title":"Hybridization of fluoro-amodiaquine (FAQ) with pyrimidines: synthesis and antimalarial efficacy of FAQ\u2013pyrimidines","volume":"10","author":"Tripathi","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112955_bib267","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01152-16","article-title":"Synthesis and evaluation of chirally defined side chain variants of 7-chloro-4-aminoquinoline to overcome drug resistance in malaria chemotherapy, antimicrob","volume":"61","author":"Dola","year":"2017","journal-title":"Agents Chemother"},{"key":"10.1016\/j.ejmech.2020.112955_bib268","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1021\/acs.jmedchem.7b00621","article-title":"Benzoxaborole antimalarial agents. Part 5. Lead optimization of novel amide pyrazinyloxy benzoxaboroles and identification of a preclinical candidate","volume":"60","author":"Zhang","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib269","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1093\/jac\/dkz290","article-title":"Development of pyridyl thiosemicarbazones as highly potent agents for the treatment of malaria after oral administration","volume":"74","author":"Parkinson","year":"2019","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib270","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejmech.2018.10.041","article-title":"Identification of novel quinazoline derivatives as potent antiplasmodial agents","volume":"161","author":"Bouchut","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib271","doi-asserted-by":"crossref","first-page":"13066","DOI":"10.1002\/anie.201907224","article-title":"Artemisinin\u2013(Iso)quinoline hybrids by C\u2212H activation and click chemistry: combating multidrug-resistant malaria","volume":"58","author":"\u00c7apc\u0131","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2020.112955_bib272","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ejmech.2017.09.040","article-title":"Synthesis and antimalarial evaluation of artesunate-polyamine and trioxolane-polyamine conjugates","volume":"140","author":"Pearce","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib273","doi-asserted-by":"crossref","first-page":"11300","DOI":"10.1021\/jacs.7b06994","article-title":"Synthesis of a bicyclic azetidine with in\u00a0vivo antimalarial activity enabled by stereospecific, directed C(sp 3 )\u2013H arylation","volume":"139","author":"Maetani","year":"2017","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2020.112955_bib274","series-title":"Compounds and Methods for the Treatment of Malaria","author":"Comer","year":"2014"},{"key":"10.1016\/j.ejmech.2020.112955_bib275","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1021\/acsmedchemlett.9b00123","article-title":"4-Aryl pyrrolidines as novel orally efficacious antimalarial agents. Part 2: 2-aryl- N -(4-arylpyrrolidin-3-yl)acetamides","volume":"10","author":"Meyers","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112955_bib276","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1021\/acsmedchemlett.9b00457","article-title":"Antimalarial N 1 , N 3 -dialkyldioxonaphthoimidazoliums: synthesis, biological activity, and structure\u2013activity relationships","volume":"11","author":"Ahenkorah","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112955_bib277","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/molecules25020299","article-title":"Synthesis and antimalarial activity of 1,4-disubstituted piperidine derivatives","volume":"25","author":"Seck","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2020.112955_bib278","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.tetlet.2019.05.054","article-title":"Microwave-assisted, rapid synthesis of 2-vinylquinolines and evaluation of their antimalarial activity","volume":"60","author":"Huang","year":"2019","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2020.112955_bib279","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02214-17","article-title":"Artemisone and artemiside are potent panreactive antimalarial agents that also synergize redox imbalance in plasmodium falciparum transmissible gametocyte stages","volume":"62","author":"Coertzen","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2020.112955_bib280","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1016\/j.bmcl.2018.08.037","article-title":"Synthesis, antimalarial activities and cytotoxicities of amino-artemisinin-1,2-disubstituted ferrocene hybrids","volume":"28","author":"de Lange","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2020.112955_bib281","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1021\/acsmedchemlett.7b00013","article-title":"Antimalarial properties of simplified kalihinol analogues","volume":"8","author":"Daub","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112955_bib282","doi-asserted-by":"crossref","first-page":"1600335","DOI":"10.1002\/ardp.201600335","article-title":"Design, synthesis, and biological evaluation of novel 1,2,4-trioxanes as potential antimalarial agents","volume":"350","author":"Gupta","year":"2017","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2020.112955_bib283","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00044-016-1769-6","article-title":"Synthesis of an organo-ruthenium aminoquinoline-trioxane hybrid and evaluation of its activity against Plasmodium falciparum and its toxicity toward normal mammalian cells","volume":"26","author":"Mart\u00ednez","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2020.112955_bib284","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/acsmedchemlett.7b00412","article-title":"Synthesis of thymoquinone\u2013artemisinin hybrids: new potent antileukemia, antiviral, and antimalarial agents","volume":"9","author":"Fr\u00f6hlich","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112955_bib285","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejmech.2018.02.048","article-title":"Endoperoxide-8-aminoquinoline hybrids as dual-stage antimalarial agents with enhanced metabolic stability","volume":"149","author":"Capela","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2020.112955_bib286","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/acsmedchemlett.8b00381","article-title":"Synthesis of artemisinin\u2013estrogen hybrids highly active against HCMV, P. Falciparum , and cervical and breast cancer","volume":"9","author":"Fr\u00f6hlich","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2020.112955_bib287","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1002\/chem.201800729","article-title":"Synthesis of artemisinin-derived dimers, trimers and dendrimers: investigation of their antimalarial and antiviral activities including putative mechanisms of action","volume":"24","author":"Fr\u00f6hlich","year":"2018","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2020.112955_bib288","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.steroids.2017.11.008","article-title":"Synthesis and antimalarial activity of 3\u2032-trifluoromethylated 1,2,4-trioxolanes and 1,2,4,5-tetraoxane based on deoxycholic acid","volume":"129","author":"Yamansarov","year":"2018","journal-title":"Steroids"},{"key":"10.1016\/j.ejmech.2020.112955_bib289","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/acsmedchemlett.9b00669","article-title":"Synthesis of novel G factor or chloroquine-artemisinin hybrids and conjugates with potent antiplasmodial activity","volume":"11","author":"Pepe","year":"2020","journal-title":"ACS Med. Chem. Lett."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420309272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523420309272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:24:07Z","timestamp":1759328647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523420309272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":289,"alternative-id":["S0223523420309272"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112955","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An insight into the recent development of the clinical candidates for the treatment of malaria and their target proteins","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2020.112955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112955"}}